Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
04/2012
04/05/2012US20120083500 Oxazolone and pyrrolidinone-substituted arylamides as p2x3 and p2x 2/3 antagonists
04/05/2012US20120083499 Novel benzenesulfonamides as calcium channel blockers
04/05/2012US20120083495 Compounds for the treatment of spinal muscular atrophy and other uses
04/05/2012US20120083494 Novel triazole derivatives with improved receptor activity and bioavailability properties as ghrelin antagonists of growth hormone secretagogue receptors
04/05/2012US20120083492 Imidazopyrazines for use as kinase inhibitors
04/05/2012US20120083489 Bis-pyridylpyridones as melanin-concentrating hormone receptor antagonists
04/05/2012US20120083488 Tetracyclic compound
04/05/2012US20120083487 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurolgical diseases, intractable and chronic pain and brain injury
04/05/2012US20120083486 Kit, composition, product or medicament for treating cognitive impairment
04/05/2012US20120083485 Noribogaine in the treatment of pain and drug addiction
04/05/2012US20120083477 Proteasome inhibitors and uses thereof
04/05/2012US20120083476 Heteroaryl-substituted spirocyclic diamine urea modulators of fatty acid amide hydrolase
04/05/2012US20120083475 Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases
04/05/2012US20120083473 Treatment of conditions by toll-like receptor modulators
04/05/2012US20120083469 Inhibitors of arginase and their therapeutic applications
04/05/2012US20120083464 Neuroprotective properties of 5'-methylthioadenosine
04/05/2012US20120083453 Treatment using neublastin polypeptides
04/05/2012US20120083452 Topical Anesthetic Uses of Szeto-Schiller Peptides
04/05/2012US20120083451 Composition for improving brain function and method for improving brain function
04/05/2012US20120083450 Cerebroprotein hydrolysate for treating brain injuries and neurodegenerative conditions effecting the brain
04/05/2012US20120083449 Treatment for anxiety
04/05/2012US20120083447 Novel Therapeutic Treatments Using Centhaquin
04/05/2012US20120083444 Emulsion Method For Preparing Low Residual Solvent Microparticles
04/05/2012US20120082729 Quick dissolve compositions and tablets based thereon
04/05/2012US20120082726 Surface-treated modafinil particles
04/05/2012US20120082683 Superagonistic Anti-CD28 Antibodies
04/05/2012US20120082672 Botulinum Neurotoxin B Receptors and Use Thereof
04/05/2012US20120082671 Modulation of activity of neurotrophins
04/05/2012US20120082667 Antibodies That Specifically Bind To A Beta Oligomers And Use Thereof
04/05/2012US20120082656 Composition comprising the purified extract of bee venom for preventing and treating degenerative brain disease
04/05/2012US20120082650 Methods for treating parkinson's disease and other disorders of dopaminergic neurons of the brain
04/05/2012US20120082636 Stabilized alpha helical peptides and uses thereof
04/05/2012US20120082635 2-amino-2- [8-(dimethyl carbamoyl)- 8-aza- bicyclo [3.2.1] oct-3-yl]-exo- ethanoyl derivatives as potent dpp-iv inhibitors
04/05/2012US20120082623 SHH Regulation and Methods Thereof
04/05/2012US20120082620 Methods and compositions for treatment of add/adhd, depression, memory problems and other conditions
04/05/2012CA2860747A1 Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same
04/05/2012CA2813189A1 Novel methylcyclohexane derivatives and uses thereof
04/05/2012CA2813013A1 Use of meteorin for the treatment of allodynia, hyperalgesia, spontaneous pain and phantom pain
04/05/2012CA2812751A1 Composition containing 2-acyl-lysophosphatidylserine and method for producing the same
04/05/2012CA2812649A1 Crystalline naloxol-peg conjugate
04/05/2012CA2812227A1 Polymorphs of 4-[2-dimethylamino-1-(1-hydroxycyclohexyl)ethyl]phenyl 4-methylbenzoate hydrochloride, methods for preparing the same and use of the same
04/05/2012CA2811192A1 1,2,4-triazolone derivative
04/05/2012CA2810954A1 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
04/04/2012EP2436696A1 Method of providing disease-specific binding molecules and targets
04/04/2012EP2436675A1 Novel -phenoxybenzeneacetic acid derivative and pharmaceutical preparation comprising same
04/04/2012EP2436673A1 Curcumin derivatives with improved physicochemical properties and nanoliposomes surface-decorated with the derivatives with very high affinity for amyloid-beta1-42 peptide
04/04/2012EP2436396A1 Novel pharmaceutical composition for prevention and/or treatment of attention deficit/hyperactivity disorder
04/04/2012EP2436387A1 Pharmaceutical composition containing nuclear factor involved in proliferation and differentiation of central neuronal cells
04/04/2012EP2436384A2 Aripiprazole oral solution
04/04/2012EP2436383A1 Oral medicinal composition and oral medicinal capsule having the composition encapsulated therein
04/04/2012EP2436375A1 Pharmaceutical compositions comprising fentanyl for intranasal delivery
04/04/2012EP2435463A2 Steroide anionic compounds, method of their production, usage and pharmaceutical preparation involving them
04/04/2012EP2435438A1 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
04/04/2012EP2435416A2 Tetrahydropyranochromene gamma secretase inhibitors
04/04/2012EP2435414A1 Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use
04/04/2012EP2435093A1 Albumin-amyloid peptide conjugates and uses thereof
04/04/2012EP2435080A2 Pharmaceutical compositions for the treatment of pain
04/04/2012EP2435061A1 Glp-1 receptor agonist compounds for sleep enhancement
04/04/2012EP2435046A1 Heterocyclic compounds for the treatment of stress-related conditions
04/04/2012EP2435044A1 Method of treating sleep disorders using the combination of eplivanserin and zolpidem
04/04/2012EP2435043A1 3-alkyl-5-fluoroindole derivatives as myeloperoxidase inhibitors
04/04/2012EP2435035A1 Methods of enhancing selective serotonin reuptake inhibitor effects in mammals
04/04/2012EP2271340B1 Pharmaceutical preparation comprising stephaglabrin sulfate for treating demyelinating diseases of the nervous system and for promoting restoration of the myelin sheath of nerve fibers
04/04/2012EP2251011B1 Solid preparation for oral administration
04/04/2012EP2212322B1 Quinolizidinone m1 receptor positive allosteric modulators
04/04/2012EP1990343B1 Azaindoles
04/04/2012EP1935881B1 Aryl-substituted nitrogen-containing heterocyclic compound
04/04/2012EP1911743B1 Cyclic amine compound
04/04/2012EP1778619B1 T type calcium channel inhibitors
04/04/2012EP1706395B1 Thiophene and furan compounds
04/04/2012EP1658277B1 Succinate and malonate salt of trans-4-(ir,3s)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament
04/04/2012EP1583529B9 Amino acid phenoxy ethers, their preparation and uses
04/04/2012EP1557414B1 Isoquinoline compounds and medicinal use thereof
04/04/2012EP1434798B1 Compounds capable of affecting differentiation, proliferation, regeneration, plasticity and survival of cells
04/04/2012CN1985993B 增强记忆力的复方制剂 Enhance memory FDC
04/04/2012CN1870993B 基于咪唑克生盐或其一种多晶型物的药物组合物 Pharmaceutical compositions based idazoxan salt or a polymorph of
04/04/2012CN1602199B Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
04/04/2012CN102405222A 2-氮杂-二环[2.2.1]庚烷化合物及其用途 2-aza - bicyclo [2.2.1] heptane compound and its use
04/04/2012CN102405213A 靶向于组胺h3受体的环丙基酰胺衍生物 Histamine receptor targeting h3 cyclopropyl amide derivative
04/04/2012CN102405079A Products comprising n-phenylpropenoyl amino acid amides and uses thereof
04/04/2012CN102405052A Composition comprising the purified extract of bee venom for preventing and treating degenerative brain diseases
04/04/2012CN102405049A 多糖类衍生物的水凝胶 Polysaccharide derivative hydrogels
04/04/2012CN102405048A 1-[2-(2,4-二甲基苯硫基)苯基]哌嗪盐的液体制剂 1- [2- (2,4-dimethoxy-phenyl thio) phenyl] piperazine in a liquid formulation
04/04/2012CN102405043A Pro-neurogenic compounds
04/04/2012CN102399831A 花生四烯酸及其生产和使用方法 Arachidonic acid and the production and use of
04/04/2012CN102399741A Culture solution and method for producing hemopoietic stem cell by reversely splitting somatic cell and application of culture liquid
04/04/2012CN102399740A Method and kit allowing reverse differentiation of human somatic cells for generation of autologous pancreatic stem cells and autologous pancreas islet, and application thereof
04/04/2012CN102399666A 人参酒及其生产工艺 Ginseng wine and its production process
04/04/2012CN102399254A 新型五环三萜衍生物、其制备方法及用途 The new pentacyclic triterpenoid derivatives, their preparation and use
04/04/2012CN102399222A 没食子酸苦参碱盐及其制剂的制备方法和用途 Gallic acid salts and preparations MATRINE preparation and use
04/04/2012CN102397526A Application of Jingzhaotoxin-V to preparation of medicine for resisting cognitive, learning and memory dysfunction
04/04/2012CN102397518A 一种治疗失眠的茶膏及其制备方法 A cream tea insomnia and its preparation method of treatment
04/04/2012CN102397503A 治疗失眠症的中草药 Herbal treatment of insomnia
04/04/2012CN102397500A Traditional Chinese medicine for treating insomnia, dreamful sleep, amnesia and irritability and improving brain memory
04/04/2012CN102397477A 心脑香通荷包 Heart and brain incense pass purse
04/04/2012CN102397465A Traditional Chinese medicine for treating nanism, activating self growth potential, invigorating brain and increasing intelligence
04/04/2012CN102397428A 一种治疗脑损伤的中药药方的制备方法 Preparation method of treating brain injury medicine prescriptions
04/04/2012CN102397419A 治疗偏瘫的中药组合物及其制备方法 Chinese medicinal composition for the treatment of hemiplegia and its preparation method
04/04/2012CN102397404A Tea paste for treating limb anesthesia dolorosa and preparation method thereof
04/04/2012CN102397399A 一种中药组合物在制备防治糖尿病并发症药物中的应用 A Chinese medicinal composition for the preparation of a medicament for the prevention and treatment of diabetic complications